Tilray reported $282.79M in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Akebia Therapeutics USD 18.7M 5.68M Sep/2026
Aurora Cannabis CAD 187.54M 12.47M Jun/2026
Avita Medical AUD 5.29M 1.64M Jun/2026
Canopy Growth CAD 107.46M 3.06M Jun/2026
Cronos Group USD 54.52M 1.82M Sep/2026
Divis Laboratories Ltd INR 39.54B 7.18B Mar/2026
Ionis Pharmaceuticals USD 28.58M 22.26M Sep/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Moderna USD 313M 33M Sep/2026
Organigram Holdings CAD 165.06M 29.9M Jun/2026
Organon & Co USD 1.36B 4M Sep/2026
Revvity USD 388.85M 10.35M Sep/2026
Tilray USD 282.79M 11.9M Jun/2025
Viatris USD 3.83B 104M Sep/2026
Xeris Pharmaceuticals USD 76.92M 4M Sep/2026
Zealand Pharma A/S 10.7M 9.9M Dec/2024